Scotiabank Boosts Welltower (NYSE:WELL) Price Target to $165.00

Welltower (NYSE:WELL) had its price objective raised by equities research analysts at Scotiabank from $144.00 to $165.00 in a report released on Friday,Benzinga reports. The firm currently has a “sector outperform” rating on the real estate investment trust’s stock. Scotiabank’s price objective would suggest a potential upside of 7.46% from the company’s previous close.

WELL has been the subject of a number of other research reports. Wedbush upgraded Welltower from a “neutral” rating to an “outperform” rating and lifted their price target for the company from $145.00 to $167.00 in a research note on Friday, February 14th. Raymond James lifted their price target on Welltower from $145.00 to $155.00 and gave the company a “strong-buy” rating in a research note on Monday, December 16th. Royal Bank of Canada upgraded Welltower from a “sector perform” rating to an “outperform” rating and lifted their price target for the company from $146.00 to $168.00 in a research note on Friday. StockNews.com downgraded Welltower from a “hold” rating to a “sell” rating in a research note on Thursday, February 13th. Finally, Jefferies Financial Group upgraded Welltower from a “hold” rating to a “buy” rating and lifted their price target for the company from $132.00 to $147.00 in a research note on Thursday, January 2nd. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, ten have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $145.96.

Welltower Stock Up 1.3 %

Shares of WELL traded up $2.02 during trading hours on Friday, hitting $153.54. The stock had a trading volume of 5,298,875 shares, compared to its average volume of 2,703,079. The company has a debt-to-equity ratio of 0.48, a current ratio of 4.22 and a quick ratio of 4.22. The firm has a 50 day simple moving average of $135.78 and a 200-day simple moving average of $131.13. The firm has a market capitalization of $98.47 billion, a P/E ratio of 98.42, a price-to-earnings-growth ratio of 2.87 and a beta of 1.23. Welltower has a 1-year low of $87.87 and a 1-year high of $153.90.

Welltower (NYSE:WELL) last issued its earnings results on Tuesday, February 11th. The real estate investment trust reported $1.13 EPS for the quarter, beating the consensus estimate of $0.40 by $0.73. Welltower had a return on equity of 3.15% and a net margin of 11.91%. Sell-side analysts predict that Welltower will post 4.88 EPS for the current fiscal year.

Institutional Investors Weigh In On Welltower

A number of hedge funds have recently modified their holdings of WELL. Laurel Wealth Advisors LLC bought a new stake in shares of Welltower in the 4th quarter worth approximately $25,000. Roxbury Financial LLC bought a new stake in shares of Welltower in the 4th quarter worth approximately $26,000. Sierra Ocean LLC bought a new stake in shares of Welltower in the 4th quarter worth approximately $28,000. Versant Capital Management Inc raised its holdings in shares of Welltower by 165.5% in the 4th quarter. Versant Capital Management Inc now owns 300 shares of the real estate investment trust’s stock worth $38,000 after purchasing an additional 187 shares during the period. Finally, Ashton Thomas Securities LLC bought a new stake in shares of Welltower in the 3rd quarter worth approximately $50,000. Institutional investors own 94.80% of the company’s stock.

About Welltower

Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.